S E Jones
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Dermatology top 10%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Lymphoma Diagnosis and Treatment 12
- Oncology 3
- Cancer Treatment and Pharmacology 2
- Global Cancer Incidence and Screening 1
- Co-authors
- C A Coltman (5 shared papers)Eugene M. McKelvey (2 shared papers)S E Salmon (3 shared papers)Petre N. Grozea (2 shared papers)Baker Lh (2 shared papers)Luce Jk (1 shared paper)Richard I. Fisher (2 shared papers)BG Durie (2 shared papers)
- Journals
- PubMed (26 papers)
- Partner nations
- United States
In The Last Decade
S E Jones
26 papers receiving 332 citations
Peers
Comparison fields: 5 of 42
- Pathology and Forensic Medicine 165
- Dermatology 45
- Hepatology 20
- Cardiology and Cardiovascular Medicine 48
- Oncology 44
Countries citing papers authored by S E Jones
This map shows the geographic impact of S E Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S E Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S E Jones more than expected).
Fields of papers citing papers by S E Jones
This network shows the impact of papers produced by S E Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S E Jones. The network helps show where S E Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside S E Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chemotherapy of non-Hodgkin's lymphoma: 10 years' experience in the Southwest Oncology Group. | 1977 | 49 |
| 2 | Combination chemotherapy for mycosis fungoides: a Southwest Oncology Group study. | 1979 | 46 |
| 3 | Combination chemotherapy with adriamycin (NSC-123127) and cyclophosphamide (NSC-26271) for solid tumors: a phase II trial. | 1976 | 37 |
| 4 | Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest oncology group study. | 1982 | 34 |
| 5 | Conclusions from clinical trials of the Southwest Oncology Group. | 1982 | 26 |
| 6 | Gallium nitrate in malignant lymphoma: a Southwest Oncology Group study. | 1983 | 26 |
| 7 | Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study. | 1977 | 25 |
| 8 | Myocardial infarction in a 27-year-old woman: possible complication of treatemtn with VP-16-213 (NSC-141540), mediastinal irradiation, or both. | 1976 | 21 |
| 9 | Noninvasive cardiac evaluation of patients receiving adriamycin. | 1978 | 21 |
| 10 | Phase II evaluation of cis-dichlorodiammineplatinum(II) in lymphomas: a Southwest Oncology Group Study. | 1980 | 20 |
| 11 | Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. | 1980 | 17 |
| 12 | Surgical restaging of Hodgkin's disease. | 1982 | 12 |
| 13 | Combination chemotherapy with adriamycin and cyclophosphamide (with or without radiation therapy) for carcinoma of the lung. | 1977 | 11 |
| 14 | 1-year followup of cardiac status after adriamycin therapy. | 1980 | 9 |
| 15 | Importance of staging in Hodgkin's disease. | 1980 | 9 |
| 16 | Phase II trial of vindesine in the treatment of lymphomas, breast cancer, and other solid tumors. | 1981 | 9 |
| 17 | Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study. | 1983 | 9 |
| 18 | "Current status of adjuvant therapy". | 1975 | 8 |
| 19 | Systematic re-staging in the management of non-Hodgkin's lymphomas. | 1977 | 8 |
| 20 | Salvage treatment of unfavorable non-Hodgkin's lymphoma with cisplatin, amsacrine, and mitoguazone: a Southwest Oncology Group Pilot Study. | 1986 | 8 |
About S E Jones
S E Jones is a scholar working on Pathology and Forensic Medicine, Oncology, Cardiology and Cardiovascular Medicine, Cancer Research and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 428 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (12 papers), Cancer therapeutics and mechanisms (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Cancer Treatment and Pharmacology (2 papers), Breast Cancer Treatment Studies (2 papers), Medical research and treatments (1 paper), Global Cancer Incidence and Screening (1 paper) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (165 citations), Dermatology (45 citations), Hepatology (20 citations), Cardiology and Cardiovascular Medicine (48 citations) and Oncology (44 citations). S E Jones has collaborated with scholars based in United States. Frequent co-authors include C A Coltman, Eugene M. McKelvey, S E Salmon, Petre N. Grozea, Baker Lh, Luce Jk, Richard I. Fisher, BG Durie, Weick Jk and Arthur H. Rossof. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.